Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)

O que é Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Malformação capilar-megalencefalia síndromes é um distúrbio de malformação múltipla. Sua gravidade varia entre os indivíduos.

Identificado pela primeira vez em 1997 como um distúrbio distinto, há apenas 140 casos relatados desde então, mas pode haver um subdiagnóstico contribuindo para esse número.

Esta rara condição de desenvolvimento envolve principalmente crescimento excessivo de tecidos em diferentes partes do corpo. Um grande cérebro (megalocefalia) é uma das principais características do síndromes.

Síndromes Sinônimos:
M-CM Macrocefalia - malformação capilar Malformação macrocefalia-capilar; Mcm Macrocephaly-cutis Marmorata Telangiectatica Congenita; Mcmtc MCAP MCTC Megalencefalia - malformação capilar Malformação megalencefalia-capilar Síndromes Megalencefalia-cutis Marmorata Telangiectatica Congenita Supercrescimento - polissindactilia - hemangiomas Supercrescimento-polissindactilia-hemangiomas

Quais mudanças genéticas causam Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Mutações somáticas no gene PIK3CA. Não se acredita que seja uma condição hereditária.

A herança do mosaico ocorre muito cedo no desenvolvimento do feto. Essencialmente, é um erro na divisão celular. O corpo humano é composto de 46 cromossomos, em 23 pares. Mosaicismo ocorre quando um indivíduo possui células em seu corpo com mais ou menos cromossomos do que o normal 46. Isso pode desencadear problemas que afetam diferentes sistemas e partes do corpo.

Quais são os principais sintomas de Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

O principal sintomas do síndromes incluem crescimento excessivo do cérebro (megalencefalia) uma cabeça grande.

Malformações capilares ou lesões cutâneas na face, tronco e membros são as principais sintoma. Uma testa proeminente, dedos das mãos e pés extras, bem como pele e articulações soltas também são sintomas do síndromes. Assim como a assimetria corporal.

Outras condições de saúde associadas ao síndromes incluem baixo tônus muscular, convulsões e defeitos cardíacos. Sintomas pode variar consideravelmente entre os indivíduos.

Possíveis traços / características clínicas:
Cavum septo pelúcido, Isquemia cerebral, Crescimento assimétrico, Malformação de Arnold-Chiari, Aplasia / Hipoplasia do cerebelo, Malformação arteriovenosa, Bossa frontal, Esporádica, Mutação somática, Defeito do septo ventricular, Angiomatose visceral, Neurocefalia cutânea, Teliomatose visceral, Teliomatose da pele anormal, migração, nefroblastoma, microftalmia, megalencefalia, meningioma, arritmia, leucemia, hipotonia muscular, macrocefalia progressiva, deficiência intelectual, hipermobilidade articular, frouxidão articular, boca larga, atrofia óptica, crescimento excessivo, sindactilia dos dedos do pé, sindactilia polidactilia, Polidactilia das mãos, Polimicrogiria, Epicanto, Olho profundamente implantado, Ventriculomegalia, Assimetria facial, Sindactilia dos dedos, Filtro liso, Cutis marmorata, Fissuras palpebrais inclinadas, Malformação do coração e dos grandes vasos, Ponte nasal deprimida, Maculismo completo, , Hidrocefalia, Testa alta, Testa larga, Hérnia, Cogn deficiência ativa, global

Como alguém faz o teste de Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

O teste inicial para Megalencefalia-Malformação Capilar-Polimicrogiria pode começar com a triagem de análise facial, através do FDNA Telehealth plataforma telegenética, que pode identificar os principais marcadores da síndromes e delinear a necessidade de mais testes. Seguirá uma consulta com um conselheiro genético e, em seguida, um geneticista. 

Com base nesta consulta clínica com um geneticista, as diferentes opções de teste genético serão compartilhadas e o consentimento será solicitado para testes adicionais.

Informações Medican sobre Megalencefalia-Malformação Capilar-Polimicrogiria Síndromes

Barnicoat et al., (1996) reported two infants with a similar syndrome of overgrowth, haemangiomas, and polydactyly associated with syndactyly. In one female infant birth weight and head circumference were above the 97th centile whereas length was between the 50th and 90th centile. Hypoglycaemia developed on day two but was easy to control and there was no evidence of hyperinsulinaemia. Hypoglycaemia and thrombocytopenia needing treatment were problems in the first few days of life. The facial features were coarse with a relatively large head. The neck was short with redundant skin folds. The nasal bridge was flat. There was a large cavernous haemangioma on the right shoulder. There was syndactyly between fingers 3-4 on both hands and post-axial polydactyly of both feet. Radiographs showed severe demineralisation of the skeleton with Wormian bones in the skull. The long bones were slender. CT brain scan showed mild periventricular leukomalacia and a mild communicating hydrocephalus initially, but intracranial pressure increased and a shunt was needed by three months. The second infant had somewhat similar features. There was no generalised macrosomia but the hands were disproportionately large. The facial features were similar to the first case. There were large capilliary haemangiomata over the palmar and dorsal aspects of both hands and on the back, as well as on both feet and legs. There was a cavernous haemangioma on the left axilla and also one on the left cheek and upper lip displacing the nose to the right. Post-axial polydactyly of the left hand with bilateral 3-4 syndactyly of the fingers with fused nails on one side were noted. There was 2-3 and 4-5 syndactyly of both feet. NMR scanning of the brain showed hydrocephalus and a venous malformation with massive dilation of the sagittal, straight and sigmoid sinuses with thrombosis.
Toriello et al., (1996), Clayton-Smith et al., (1997) and Moore et al., (1997) reported a group of children with a distinctive overgrowth syndrome. This is characterised by macrocephaly, limb asymmetry, and vascular stains. Birth weight is increased. There were cutis marmorata and a characteristic haemangioma of the philtrum of the upper lip. These cutaneous features may fade with age. Carcao et al., (1998) reported a case where MRI scans showed protrusion of the cerebellar tonsils through the foramen magnum, a lumbar syrinx and ""hydrops of the optic nerves"".
Franceschini et al., (2000) reported two convincing cases without cutis marmorata. The patient reported by Hallett et al., (1995) seems to have features of the condition although there was also acanthosis nigricans and gingival fibromatosis. Yano and Watanabe (2001) reported three cases of poor clinical outcomes. In two cases there were intractable cardiac arrhythmias and sudden death. Robertson et al., (2000) reported five further cases and provide a good review. Lapunzina et al., (2004) have done the same. Schwartz et al., (2002) reported a male with some features of the condition (although not entirely convincing) who had a retinoblastoma. It seems likely that the case reported by Megarbane et al., (2003) with polydactyly and intestinal lymphangiectasia falls into this group. A case reported by Stoll (2003) had a t(2;17)(p11;p13) translocation.
Garavelli et al., (2005) looked at the MRI findings of 10 cases and found abnormalities in all (megalencephaly, asymmetry, increased white matter signals). Giuliano et al., (2004) reported seven cases and stress the neurological sequelae (all were delayed, five cases had cerebral asymmetry with hemimegalencephaly in three, hydrocephalus in three and an Arnold-Chiari type I in one).
The neurological features of 17 patients were discussed by Conway et al., (2007). White matter irregularities (increased signal on T2-weighted images) were found in the majority and a distinctive feature was cerebellar tonsilar herniation and progressive crowding of the posterior fossa. This, postulated the authors, suggested a dynamic process, possibly initiated by a rapidly growing cerebellum, congestion of venous drainage and an increase in pressure, that led, in some of their cases, to tonsillar herniation. They also found evidence of an abnormal cortical morphogenesis.
A long-term follow-up of a case reported by Canham and Holder (2008) showed that growth and head circumference ended up just within the normal range, that the vascular skin lesions faded with time. Only the varicosities (in this case mild) remained.
Note however that of the 12 cases reported by Wright et al., (2009), all showed a reticulated or confluent port-wine stain (not cutis marmorata) and seven had centrofacial capillary malformations. There is macrocephaly with ventricular dilatation. Syndactyly between toes 2 and 3 is common and there may be limb asymmetry. Some cases have 3/4 syndactyly of the fingers and occasionally post-axial polydactyly. Congenital heart defects have occasionally occurred (Dinleyici et al., 2005, Gonzalez et al., 2009). There may also be joint laxity and hyperelastic skin. Developmental delay is common. MRI scans may show evidence of delayed myelination. Hydrocephalus usually develops. Apnoe due to cranio-cervical cord compression has also been reported (Franklin et al., 2009). See under Hemihypertrophy-hemimegalencephaly-polydactyly for a condition with similar features. Proteus syndrome has to be considered. Note the three cases reported by Gonzalez et al., (2009) who state that unlike Proteus there may be checker-board pattern to the hypertrophy ie., face, and then the leg opposite to the trunk). They also state that unlike Proteus the hypertrophy occurs irrespective of the vascular stain.
The clinical features and diagnostic criteria are well reviewed by Martinez-Glez et al., (2010).
Polymicrogyria and a thickened corpus callosum are also features (Mirzaa et al., 2012).
The case reported by Papetti et al., (2012) had hemimegalencephaly, polymicrogyria and cerebellar tonsillar herniation.
Discordant monozygotic twins were reported by Lederer et al., (2012). Note the excellent paper by Reviere et al., (2012) who looked at three families with either MPPH or MCAP and thereafter further cases, They found two mutations in AKT3, one in PIK3R2 in 11 unrelated families with MPPH and 15, mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and one with MPPH. It could be that PTPN11 is also involved (Docker et al., 2015).
McDermott et al., (2016) detected the presence of PIK3CA mutation in hair and in the secondary tooth of the affected individual. Dental crowding as the clinical manifestation of the PIK3CA mutation within the dental tissue has been suggested by Canham and Holder (2008).
Mirzaa et al., (2016) identified PIK3CA mutations in 60 individuals in a cohort of 181 individuals with brain and body overgrowth. Sixteen of 29 PIK3CA mutations were novel. The phenotypes were not simply related to the level and distribution of PIK3CA mutations, but also to the class of mutation. The clinical presentation was as follows: (1) severe focal overgrowth due to low-level but highly activating hotspot mutations, (2) predominantly brain overgrowth and less severe somatic overgrowth due to less-activating mutations, (3) intermediate phenotypes (capillary malformations with overgrowth) with intermediately activating mutations. Levels of mosaicism were on average lower in peripheral blood lymphocytes than saliva, and lower in saliva than in skin fibroblasts. In ten patients germline or apparently germline PIK3CA mutations were identified.
Yeung et al., (2017) described seven molecularly confirmed patients with PIK3CA-Related Overgrowth Spectrum. Clinical presentations included congenital lipomatous overgrowth, vascular malformations, epidermal nevi, scoliosis and other skeletal abnormalities, Klippel–Trenaunay syndrome, lymphatic malformations. Two individuals showed atypical phenotypes that cannot be classified into existing disease categories. The age of patients ranged from three to 18 years. Central nervous system was unaffected in all the patients.
Takagi et al., (2017) described a boy with megalencephaly and a de novo heterozygous missense mutation in the AKT3 gene. Clinical characteristics included hypotonia, developmental delay, frontal bossing, flattened nasal bridge and hyperlaxity. Novel features were transient hypoglycemia, and growth hormone deficiency.
Alcantara et al., (2017) described 14 additional patients with AKT3 mutations. Patients with highly asymmetric cortical dysplasia usually had the common p.E17K mutation; patients with constitutional AKT3 mutations showed more variable phenotypes (bilateral cortical malformations, polymicrogyria, periventricular nodular heterotopia, diffuse megalencephaly without cortical dysplasia).
Steiner et al., (2018) described six patients with PIK3CA gene mutation-related segmental overgrowth syndromes. All patients had a history of previous surgery and four of them developed abnormal scarring in tissue affected by overgrowth.
A male patient polymicrogyria in association with hypoglycemia was described by Stutterd et al. (2018). Ventriculomegaly and macrocephaly were noted prenatally. At birth, he showed overgrowth, relative macrocephaly with frontal bossing, coarse facies, broad and upturned nasal tip, full upper lip, low-set ears with squared helix, capillary malformations, redundant skin on hands and feet, and mild lateral deviation of fingers. Brain MRI showed megalencephaly and severe hydrocephalus that required ventriculoperitoneal shunt. Asymptomatic preprandial hypoglycemia, and episodes of atrial ectopic tachycardia were also documented.

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Seja mais rápido e preciso Diagnóstico Genético!

Mais de 250,000 pacientes analisados com sucesso!
Não espere anos por um diagnóstico. Aja agora e economize um tempo valioso.

Começa aqui!

"Nosso caminho para o diagnóstico de uma doença rara foi uma jornada de 5 anos que só posso descrever como uma viagem sem mapa. Não sabíamos nosso ponto de partida. Não sabíamos nosso destino. Agora nós temos esperança. "

Imagem

Paula e Bobby
Pais de lillie

O que é FDNA Telehealth?

A FDNA Telehealth é uma empresa líder em saúde digital que fornece acesso mais rápido a análises genéticas precisas.

Com uma tecnologia hospitalar recomendada pelos principais geneticistas, nossa plataforma exclusiva conecta pacientes a Especialistas Em Genética para responder às suas perguntas mais urgentes e esclarecer quaisquer dúvidas que possam ter sobre seus Sintomas.

Benefícios do FDNA Telehealth

Ícone FDNA

Credibility

Nossa plataforma é usada atualmente por mais de 70% dos geneticistas e tem sido usada para diagnosticar mais de 250,000 pacientes em todo o mundo.

Ícone FDNA

Acessibilidade

O FDNA Telehealth fornece análise facial e triagem em minutos, seguido por acesso rápido a conselheiros genéticos e geneticistas.

Ícone FDNA

Fácil de usar

Nosso processo contínuo começa com um diagnóstico online inicial por um conselheiro genético e segue por consultas com geneticistas e testes genéticos.

Ícone FDNA

Acurácia - Precisão

Recursos e tecnologia avançada de inteligência artificial (AI) com uma taxa de precisão de 90% para uma maior precisão análise genética.

Ícone FDNA

Valor para
Dinheiro

Acesso mais rápido a conselheiros genéticos, geneticistas, testes genéticos e um diagnóstico. Em até 24 horas, se necessário. Economize tempo e dinheiro.

Ícone FDNA

Privacidade e segurança

Garantimos a máxima proteção de todas as imagens e informações do paciente. Seus dados estão sempre protegidos, protegidos e criptografados.

O FDNA Telehealth pode aproximar você de um diagnóstico.
Agende uma reunião de Aconselhamento Genitico online dentro de 72 horas!

EspañolDeutschPortuguêsFrançaisEnglish